Pharma News

Alnylam must wait a few months longer for a verdict on its potential blockbuster-in-waiting vutrisiran.

With tax day right around the corner in the U.S., Merck & Co. is the latest Big Pharma to find itself in the crosshairs of a congressional tax probe.

The European Commission has approved Immunocore’s T-cell receptor (TCR) bispecific immunotherapy drug Kimmtrak (tebentafusp) for HLA-A*02:01-positive adult patients with unresectable or metastat...

The FDA has placed a partial hold on Curis’ phase 1/2a clinical trial of emavusertib in adult patients with relapsed/refractory (R/R) acute myelogenous leukemia (AML) or high-risk myelodysplasti...

Animal studies show live biotherapeutic produced by gut-healthy probiotic bacteria is safe, reduces treatment complications.

A new tool speeds up development of vaccines and other pharmaceutical products by more than 1 million times while minimizing costs.

Pfizer has recalled a single batch of its blood pressure drug, Accuretic (quinapril HCl/hydrochlorothiazide), in the UK following the detection of a nitrosamine contaminant, N-nitroso-quinapril, a...

The FDA has pushed back its decision date for Merck’s supplemental Biologics License Application (sBLA) for its 15-valent pneumococcal conjugate vaccine for pediatric patients by three months to...

The UK’S National Institute for Health and Care Excellence (NICE) has recommended Amgen’s Evenity (romosozumab) for use by the National Health Service (NHS) for the treatment of postmenopausal...

Merck has released positive results from a phase 3 study of its investigational oral antiviral COVID-19 drug Lagevrio (molnupiravir).

Estosterone undecanoate (Tlando; Antares Pharma, Inc) is indicated as testosterone replacement therapy for conditions associated with a deficiency or absence of endogenous testosterone in adult pat...

Most of us know someone affected by hearing loss, but we may not fully appreciate the hardships that lack of hearing can bring.